(IMGN) Forecast

News Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

(IMGN) Stock Quotes, Forecast and News Summary

IMGN stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	- / -
Day Range	- - -
52 Wk Range	- - -
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange
RSI	0
Short Interest	-
Days to Cover	5

Recent News

AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue and Profit Fall

AbbVie reports Q4 earnings with adjusted EPS at $2.79, beating consensus. Sees FY 2024 EPS of $11.05-$11.25. Raises 2027 outlook for key products.

Vandana Singh

AbbVie's Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures

AbbVie's growth outlook in 2024 as William Blair upgrades, highlighting strong performance in Humira erosion management, strategic acquisitions, and a 3.8% dividend yield.

Vandana Singh

Cramer Says This Major Healthcare Stock Is 'Ridiculously Cheap And Doing So Many Great Things'

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Realty Income (NYSE: O) and recommends staying with it. "It’s a very steady story," he noted.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

2.3

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

N/A

Industry

N/A

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.